2 options
Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Department of Health and Human Services. Office of Inspector General, author.
- Language:
- English
- Subjects (All):
- Medicare.
- Medicaid.
- Pharmaceutical services insurance--United States--Auditing.
- Pharmaceutical services insurance.
- Drugs--Prices--United States.
- Drugs.
- Brand name products--Prices--United States.
- Brand name products.
- Brand name products--Prices.
- Drugs--Prices.
- United States.
- Medical Subjects:
- Medicare.
- Medicaid.
- Physical Description:
- 1 online resource (iv, 22 pages) : color illustrations
- Place of Publication:
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2011.
- Notes:
- Title from title screen (viewed June 23, 2016).
- "August 2011."
- "OEI-03-10-00320."
- Includes bibliographical references.
- OCLC:
- 952178269
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.